0
Skip to Content
Medical Oncology Group of Australia
About MOGA
What is Oncology?
Governance
Contact MOGA
ASM 2026
Program
Speakers
Social Program
Abstract Submissions
Member Benefits
Join MOGA
Trainees
Young Oncologists
Committees
Honorary Members
Annual General Meeting (AGM)
Education Programs
Awards
Mentorship
Oncology Positions Vacant
Position Statements & Guidelines
Clinician Wellbeing
Resources
Sector News
Related Events
Medical Oncology Group of Australia
About MOGA
What is Oncology?
Governance
Contact MOGA
ASM 2026
Program
Speakers
Social Program
Abstract Submissions
Member Benefits
Join MOGA
Trainees
Young Oncologists
Committees
Honorary Members
Annual General Meeting (AGM)
Education Programs
Awards
Mentorship
Oncology Positions Vacant
Position Statements & Guidelines
Clinician Wellbeing
Resources
Sector News
Related Events
Folder: ABOUT
Back
About MOGA
What is Oncology?
Governance
Contact MOGA
Folder: ASM
Back
ASM 2026
Program
Speakers
Social Program
Abstract Submissions
Folder: MEMBERSHIP
Back
Member Benefits
Join MOGA
Trainees
Young Oncologists
Committees
Honorary Members
Annual General Meeting (AGM)
Folder: EDUCATION PROGRAMS
Back
Education Programs
Awards
Mentorship
Folder: RESOURCES
Back
Oncology Positions Vacant
Position Statements & Guidelines
Clinician Wellbeing
Resources
Sector News
Related Events
Changes to PBS indications for Nivolumab and Ipilimumab
Justine Orava 3/2/26 Justine Orava 3/2/26

Changes to PBS indications for Nivolumab and Ipilimumab

Read More
MOGA Young Oncologist to Represent Australia at Korean Society of Medical Oncology Annual Meeting 2026
Justine Orava 3/2/26 Justine Orava 3/2/26

MOGA Young Oncologist to Represent Australia at Korean Society of Medical Oncology Annual Meeting 2026

Read More
MOGA Executive Report – October 2025
Justine Orava 10/31/25 Justine Orava 10/31/25

MOGA Executive Report – October 2025

Read More
PBAC September Intracycle Outcomes – Multi-Indication Listing for Nivolumab + Ipilimumab
Medical Oncology Group 10/21/25 Medical Oncology Group 10/21/25

PBAC September Intracycle Outcomes – Multi-Indication Listing for Nivolumab + Ipilimumab

Read More
Health Technology Assessment (HTA) Review Implementation Advisory Group (IAG); Interim Report Released
Medical Oncology Group 9/30/25 Medical Oncology Group 9/30/25

Health Technology Assessment (HTA) Review Implementation Advisory Group (IAG); Interim Report Released

Read More
Introducing the New Look MOGA Leadership and Executive  
Medical Oncology Group 9/9/25 Medical Oncology Group 9/9/25

Introducing the New Look MOGA Leadership and Executive  

Read More
Report June 2025 - Medical Oncology Group of Australia (MOGA)
Guest User 6/12/25 Guest User 6/12/25

Report June 2025 - Medical Oncology Group of Australia (MOGA)

Read More
Members Update | National Oncology Drugs Shortages  
Guest User 3/3/25 Guest User 3/3/25

Members Update | National Oncology Drugs Shortages  

Read More
Newer Posts

CONNECT WITH US

MOGA Secretariat

145 Macquarie Street

Sydney NSW 2000 Australia

moga@moga.org.au

MOGA is registered with the Australian Taxation Office as an Income Tax Exempt Charitable Entity. Donations $2 and over are tax deductible

Quick links

Join MOGA

Education Programs

Get Involved

Sponsor a Program

Conflict of Interest (COI) Form

Survey Policy

MOGA acknowledges Traditional Owners of Country throughout Australia where our members reside and practice and recognises the continuing connection to lands, waters and communities. We pay our respect to Aboriginal and Torres Strait Islander cultures; and to Elders past and present. Aboriginal and Torres Strait Islander peoples should be aware that this website contains images or names of people who have passed away

Privacy Policy